Palivizumab
Palivizumab (MEDI 493), a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection.
Read more
€0.00
(tax incl.)
Reference:
HY-P9944
Brand: